IP Library Assignment 041645/0897
Patent Assignment
Reel/Frame 041645/0897

Assignment of Assignor's Interest

Recorded: 2017-03-20 Pages: 5
Assignor
MATTERN PHARMA AG
Executed: 2017-03-18
Assignee
M ET P PHARMA AG
SCHYNWEG 7, EMMETTEN, 6376, SWITZERLAND
Covered Properties (10)
Controlled Release Delivery System for Nasal Applications and Method of Treatment
Patent: 8,784,882 →
Application: 13/194,853 →
Publication: US 2012/0058176
Controlled Release Delivery System for Nasal Application of Neurotransmitters
Patent: 9,186,320 →
Application: 13/194,926 →
Publication: US 2012/0009249
Controlled Release Delivery System for Nasal Applications
Patent: 8,574,622 →
Application: 13/194,928 →
Publication: US 2012/0009250
Controlled Release Delivery System for Nasal Applications
Patent: 8,877,230 →
Application: 13/316,494 →
Publication: US 2012/0083480
Controlled Release Delivery System for Nasal Applications and Methods of Treatment
Patent: 8,784,869 →
Application: 13/547,774 →
Publication: US 2012/0277202
Use of a Container of an Inorganic Additive Containing Plastic Material
Patent: 8,609,043 →
Application: 13/567,878 →
Publication: US 2012/0297730
Controlled Release Delivery System for Nasal Applications and Method of Treatment
Patent: 9,238,072 →
Application: 14/322,319 →
Publication: US 2015/0005271
Controlled Release Delivery System for Nasal Application of Neurotransmitters
Patent: 9,801,834 →
Application: 14/881,332 →
Publication: US 2016/0089347
Controlled Release Delivery System for Nasal Applications and Method of Treatment
Patent: 9,579,280 →
Application: 14/965,137 →
Publication: US 2016/0136090
Controlled Release Delivery System for Nasal Applications and Method of Treatment
Patent: 9,962,394 →
Application: 15/403,627 →
Publication: US 2017/0189414
Related Assignments (3)
Other recorded transfers of the patents in this record — the chain of ownership.
Merger Feb 25, 2014
From: M & P PATNT AKTIENGESELLSCHAFT
To: MATTERN PHARMA AG
Reel/Frame 032291/0349 →
Corrective Assignment to Correct the to Correct the Assignor from M & P Patnt Aktiengesellschaft to M & P Patent Aktiengesellschaft Previously Recorded on Reel 032291 Frame 0349. Assignor(S) Hereby Confirms the Merger Effective 02/04/2014. Mar 10, 2014
From: M & P PATENT AKTIENGESELLSCHAFT
To: MATTERN PHARMA AG
Reel/Frame 032422/0169 →
Release of Security Interest Oct 9, 2018
From: MIDCAP FUNDING V TRUST
To: ACERUS PHARMACEUTICALS SRL
Reel/Frame 047207/0254 →